D-1333-2019 Class II Terminated
FDA drug recall D-1333-2019 was initiated by Pharm D Solutions, LLC on May 23, 2019 and is designated Class II. Reason for recall: Lack of Sterility Assurance. The recall status is terminated (terminated Feb 5, 2021). Affected quantity: 100 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 19, 2019
- Initiation Date
- May 23, 2019
- Termination Date
- Feb 5, 2021
- Voluntary/Mandated
- FDA Mandated
- Product Quantity
- 100 vials
Product description
Sermorelin/GHRP-2 & 6 (3-3-3 MG) vials, Pharm D. Solutions 1304 South Loop West, Houston, TX 77054, 1-844-263-6846
Reason for recall
Lack of Sterility Assurance.
Distribution pattern
Nationwide within the United States
Code information
Lot #: 12062018:17 Exp. 06/04/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1333-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026